Putnam Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $43.2M | Sell |
|
|||||
|
2023
Q3 | $37.9M | Sell |
|
|||||
|
2023
Q2 | $39M | Sell |
|
|||||
|
2023
Q1 | $37.5M | Sell |
|
|||||
|
2022
Q4 | $38.7M | Sell |
|
|||||
|
2022
Q3 | $41.5M | Sell |
|
|||||
|
2022
Q2 | $53.1M | Buy |
|
|||||
|
2022
Q1 | $44.1M | Sell |
|
|||||
|
2021
Q4 | $39.9M | Sell |
|
|||||
|
2021
Q3 | $94.1M | Sell |
|
|||||
|
2021
Q2 | $107M | Buy |
|
|||||
|
2021
Q1 | $103M | Sell |
|
|||||
|
2020
Q4 | $325M | Buy |
|
|||||
|
2020
Q3 | $332M | Sell |
|
|||||
|
2020
Q2 | $411M | Buy |
|
|||||
|
2020
Q1 | $326M | Buy |
|
|||||
|
2019
Q4 | $244M | Sell |
|
|||||
|
2019
Q3 | $210M | Buy |
|
|||||
|
2019
Q2 | $210M | Sell |
|
|||||
|
2019
Q1 | $221M | Sell |
|
|||||
|
2018
Q4 | $243M | Sell |
|
|||||
|
2018
Q3 | $310M | Sell |
|
|||||
|
2018
Q2 | $298M | Buy |
|
|||||
|
2018
Q1 | $279M | Buy |
|
|||||
|
2017
Q4 | $218M | Buy |
|
|||||
|
2017
Q3 | $164M | Buy |
|
|||||
|
2017
Q2 | $639K | Sell |
|
|||||
|
2017
Q1 | $44M | Buy |
|
|||||
|
2016
Q4 | $29.2M | Sell |
|
|||||
|
2016
Q3 | $34.9M | Sell |
|
|||||
|
2016
Q2 | $46.9M | Buy |
|
|||||
|
2016
Q1 | $14.9M | Sell |
|
|||||
|
2015
Q4 | $23.7M | Sell |
|
|||||
|
2015
Q3 | $70.7M | Buy |
|
|||||
|
2015
Q2 | $33M | Sell |
|
|||||
|
2015
Q1 | $42.3M | Sell |
|
|||||
|
2014
Q4 | $44.4M | Sell |
|
|||||
|
2014
Q3 | $103M | Sell |
|
|||||
|
2014
Q2 | $94.2M | Buy |
|
|||||
|
2014
Q1 | $41.3M | Sell |
|
|||||
|
2013
Q4 | $45.9M | Buy |
|
|||||
|
2013
Q3 | $46.8M | Buy |
|
|||||
|
2013
Q2 | $39.7M | Buy |
|